Discovery of a chemical probe for PRDM9

被引:29
作者
Allali-Hassani, Abdellah [1 ]
Szewczyk, Magdalena M. [1 ]
Ivanochko, Danton [1 ,2 ,3 ]
Organ, Shawna L. [1 ]
Bok, Jabez [4 ]
Ho, Jessica Sook Yuin [4 ]
Gay, Florence P. N. [4 ]
Li, Fengling [1 ]
Blazer, Levi [1 ]
Eram, Mohammad S. [1 ]
Halabelian, Levon [1 ]
Dilworth, David [1 ]
Luciani, Genna M. [1 ]
Lima-Fernandes, Evelyne [1 ]
Wu, Qin [1 ]
Loppnau, Peter [1 ]
Palmer, Nathan [4 ]
Talib, S. Zakiah A. [4 ]
Brown, Peter J. [1 ]
Schapira, Matthieu [1 ,5 ]
Kaldis, Philipp [4 ,6 ]
O'Hagan, Ronan C. [7 ]
Guccione, Ernesto [4 ,8 ,9 ,10 ,11 ]
Barsyte-Lovejoy, Dalia [1 ,12 ]
Arrowsmith, Cheryl H. [1 ,2 ,3 ]
Sanders, John M. [7 ]
Kattar, Solomon D. [7 ]
Bennett, D. Jonathan [7 ]
Nicholson, Benjamin [7 ]
Vedadi, Masoud [1 ,5 ]
机构
[1] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada
[2] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
[4] ASTAR, IMCB, Singapore, Singapore
[5] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada
[6] NUS, Dept Biochem, Singapore 117597, Singapore
[7] Merck & Co Inc, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA
[8] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA
[9] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[10] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA
[11] Icahn Sch Med Mt Sinai, Mt Sinai Ctr Therapeut Discovery, New York, NY 10029 USA
[12] Nat Res Ctr, Akademijos 2, Vilnius, Lithuania
基金
巴西圣保罗研究基金会; 加拿大自然科学与工程研究理事会; 加拿大创新基金会;
关键词
PR DOMAIN; HISTONE; GENE;
D O I
10.1038/s41467-019-13652-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
PRDM9 is a PR domain containing protein which trimethylates histone 3 on lysine 4 and 36. Its normal expression is restricted to germ cells and attenuation of its activity results in altered meiotic gene transcription, impairment of double-stranded breaks and pairing between homologous chromosomes. There is growing evidence for a role of aberrant expression of PRDM9 in oncogenesis and genome instability. Here we report the discovery of MRK-740, a potent (IC50: 80 +/- 16 nM), selective and cell-active PRDM9 inhibitor (Chemical Probe). MRK-740 binds in the substrate-binding pocket, with unusually extensive interactions with the cofactor S-adenosylmethionine (SAM), conferring SAM-dependent substratecompetitive inhibition. In cells, MRK-740 specifically and directly inhibits H3K4 methylation at endogenous PRDM9 target loci, whereas the closely related inactive control compound, MRK-740-NC, does not. The discovery of MRK-740 as a chemical probe for the PRDM subfamily of methyltransferases highlights the potential for exploiting SAM in targeting SAM-dependent methyltransferases.
引用
收藏
页数:11
相关论文
共 38 条
[1]   Role of the active-site solvent in the thermodynamics of factor Xa ligand binding [J].
Abel, Robert ;
Young, Tom ;
Farid, Ramy ;
Berne, Bruce J. ;
Friesner, Richard A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (09) :2817-2831
[2]  
Altemose N, 2017, ELIFE, V6, DOI [10.7554/e.Life.28383, 10.7554/eLife.28383]
[3]  
[Anonymous], 2000, Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis
[4]   PRDM9 Is a Major Determinant of Meiotic Recombination Hotspots in Humans and Mice [J].
Baudat, F. ;
Buard, J. ;
Grey, C. ;
Fledel-Alon, A. ;
Ober, C. ;
Przeworski, M. ;
Coop, G. ;
de Massy, B. .
SCIENCE, 2010, 327 (5967) :836-840
[5]   PR Domain-containing Protein 7 (PRDM7) Is a Histone 3 Lysine 4 Trimethyltransferase [J].
Blazer, Levi L. ;
Lima-Fernandes, Evelyne ;
Gibson, Elisa ;
Eram, Mohammad S. ;
Loppnau, Peter ;
Arrowsmith, Cheryl H. ;
Schapira, Matthieu ;
Vedadi, Masoud .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (26) :13509-13519
[6]   Structural Chemistry of the Histone Methyltransferases Cofactor Binding Site [J].
Campagna-Slater, Valerie ;
Mok, Man Wai ;
Nguyen, Kong T. ;
Feher, Mildos ;
Najmanovich, Rafael ;
Schapira, Matthieu .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (03) :612-623
[7]   Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery [J].
Copeland, Robert A. .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2018, 373 (1748)
[8]   Protein methyltransferases as a target class for drug discovery [J].
Copeland, Robert A. ;
Solomon, Michael E. ;
Richon, Victoria M. .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (09) :724-732
[9]   Homogeneous Assay for Target Engagement Utilizing Bioluminescent Thermal Shift [J].
Dart, Melanie L. ;
Machleidt, Thomas ;
Jost, Emily ;
Schwinn, Marie K. ;
Robers, Matthew B. ;
Shi, Ce ;
Kirkland, Thomas A. ;
Killoran, Michael P. ;
Wilkinson, Jennifer M. ;
Hartnett, James R. ;
Zimmerman, Kristopher ;
Wood, Keith V. .
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (06) :546-551
[10]   Re-engineering the zinc fingers of PRDM9 reverses hybrid sterility in mice [J].
Davies, Benjamin ;
Hatton, Edouard ;
Altemose, Nicolas ;
Hussin, Julie G. ;
Pratto, Florencia ;
Zhang, Gang ;
Hinch, Anjali Gupta ;
Moralli, Daniela ;
Biggs, Daniel ;
Diaz, Rebeca ;
Preece, Chris ;
Li, Ran ;
Bitoun, Emmanuelle ;
Brick, Kevin ;
Green, Catherine M. ;
Amerini-Otero, R. Daniel C. ;
Myers, Simon R. ;
Donnelly, Peter .
NATURE, 2016, 530 (7589) :171-+